Peter Adamson, MD

Peter Adamson, MD

Pediatric Hematology & Oncology Philadelphia, PA

Chair, Children's Oncology Group Chief, Division of Clinical Pharmacology & Therapeutics

Office Address

  • 3501 Civic Center Blvd, CTRB 10060
    Children's Hospital Of Philadelphia
    Philadelphia, PA 19104
    Phone: (215) 590-6359
    Fax: (215) 590-7544

Peter Adamson, MD

Pediatric Hematology & Oncology Philadelphia, PA

Chair, Children's Oncology Group Chief, Division of Clinical Pharmacology & Therapeutics

Clinical Specialties & Interests

  • Pediatric Hematology & Oncology: General Pediatric Hematology & Oncology

Faculty Appointments & Work History

  • ProfessorThe Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine
    Associate Professor of Pediatrics (1999-2006); Associate Professor of Pharmacology (2001-2006); Director, Office of Clinical and Translational Research (2005-present); Professor of Pediatrics and Pharmacology (2006-present)
  • DirectorThe Joseph Stokes, Jr. Research Institute of The Children's Hospital of Philadelphia
    Philadelphia, PA
  • Attending PhysicianPediatric Oncology Branch, NCI
  • InvestigatorNational Cancer Institute
    Bethesda, MD
    Research Scholar (1992-1994); Investigator (1995-1999)

Education & Training

  • NIH Clinical Ctr
  • NIH Clinical Ctr
  • Children's Hospital of PhiladelphiaChildren's Hospital of Philadelphia
  • Children's Hospital of PhiladelphiaChildren's Hospital of Philadelphia
  • Weill Cornell Medical College of Cornell UniversityWeill Cornell Medical College of Cornell University
  • Wesleyan University

Certifications & Licensure

  • PA State Medical LicensePA State Medical License1986 - 2016
  • American Board of PediatricsPediatric Hematology-Oncology

    Awards, Honors, & Recognition

    • America's Top DoctorsCastle Connolly, 2014, 2013, 2012, 2011, 2010, 2009, 2008
    • America's Top Doctors for CancerCastle Connolly, 2013, 2012, 2011, 2010, 2009, 2008, 2007, 2006
    • Philadelphia MagazineCastle Connolly, 2012, 2011, 2010, 2008, 2007, 2006

    Clinical Trials

    Publications & Presentations


    Journal Articles

    • Acute pancreatitis following ifosfamide.  Izraeli S, Adamson PC, Blaney SM, Balis FM, Cancer; 74(5):1627-1628
    • A phase I trial of amifostine (WR-2721) and melphalan in pediatric patients with advanced neoplastic disease.  Adamson PC, Balis FM, Belasco JE, Lange B, Berg SL, Blaney SM, Craig C, Poplack DG, Cancer Res; 55:4069-4072
    • Pharmacokinetics of 9-cis-retinoic acid in the rhesus monkey.  Adamson PC, Murphy RF, Godwin KA, Ulm EH, Balis FM, Cancer Res; 55(3):482-485

    Books/Book Chapters

    • Drug resistance in leukemia and lymphoma: The clinical value of laboratory studies. Chapter: Pharmacologic factors involved in the response to chemotherapy: apparent versus intrinsic drug resistance Page 33 - 39
      Adamson P, Poplack D
      Editors: Kaspers GJL, Pieters R, Twentyman PR, Wiesenthal LM, Veerman AJP.Harwood Academic Publishers, Chur, Switzerland
    • Cancer in the Nervous System. Chapter: Pharmacologic approaches to treatment of meningeal metastases Page 291 - 301
      Adamson PC, Poplack DG
      Editors: Levin VA.Churchill Livingstone, New York
    • Making better drugs for children with cancer.  
      National Cancer Policy Board (U.S.). Committee on Shortening the Time Line for New Cancer Treatments., Adamson PC, Weiner SL, Simone JV, Gelband H
      Editors: .National Academies Press, Washington, D.C


    • Phase I study of sorafenib in children with refractory solid tumors: A Children's Oncology Group Phase I Consortium trial. Widemann BC, Fox E, Adamson PC, Baruchel S, Kim A, Ingle AM, Bender JG, Stempak D, Balis FM, Blaney SM, ASCO Meeting Abstracts
    • Modeling MLN8237, an aurora kinase a inhibitor, with irinotecan (IRN) and temozolomide (TMZ) in neuroblastoma (NB). Lipsitz EG, Nguyen V, Zhao H, Ecsedy J, Maris JM, Adamson PC, Mosse YP, ASCO Meeting Abstracts; 28(15_suppl):10593. PMID
    • A pediatric phase I trial and pharmacokinetic study of MLN8237, an oral selective small molecule inhibitor of aurora a kinase: A Children's Oncology Group Phase I Cons... Mosse YP, Lipsitz EG, Maris JM, Weigel B, Adamson PC, Ingle M, Ahern CH, Blaney S, ASCO Meeting Abstracts; 28(15_suppl):9529


    • Early Phase Cancer Drug Development in Children. Philadelphia, PA, 2007; Boulder, CO, 2008
    • Development of Targeted Therapy for Children with Cancer. Ely Brent Visiting Professor The Children’s Hospital, Denver Cancer Center Rounds
    • New Agents for Children with Cancer. Pediatric Grand Rounds, Denver, CO

    Insurance Accepted

    • Aetna Choice POS II
    • Aetna HMO
    • AmeriHealth Direct POS
    • AmeriHealth Direct POS Value Network
    • Amerihealth HMO
    • AmeriHealth HMO Value Network
    • AmeriHealth PPO
    • AmeriHealth PPO Value Network
    • BCBS Blue Card PPO
    • BCBS Illinois PPO
    • CIGNA Open Access
    • Cofinity PPO
    • Coventry Carelink Health Plans PPO
    • First Health PPO
    • Great West PPO
    • Health Net Arizona HMO
    • Health Net Arizona PPO/POS
    • Horizon BCBS Direct Access
    • Horizon BCBS HMO
    • Horizon BCBS POS
    • Horizon BCBS PPO
    • Humana ChoiceCare Network PPO
    • IBC Keystone HMO / POS
    • IBC Personal Choice PPO
    • Multiplan PPO
    • Oxford Health Freedom
    • Oxford Health Liberty
    • QualCare HMO
    • QualCare PPO
    • United Healthcare - Direct Choice Plus POS
    • United Healthcare - Direct Options PPO
    • The full profile is locked and available to verified physicians only.
      Join over 60% of U.S. physicians already on Doximity and get access to this and over 700,000 physician CVs. Find your physician profile

    Physicians, view Dr. Adamson's full Doximity profile to:

    • Trade HIPAA-secure messages
    • Send and receive online faxes
    • Refer a patient
    • See their complete CV